Suntra MedTech Solutions, formerly Sunrise Labs, has rebranded to reflect its expanded role in the medical technology sector. Bryan Gilpin, the company’s president, explained that the new name symbolizes the company’s roots while pointing to the future. Gilpin is a hands-on, engineering-oriented executive with experience developing, manufacturing, selling, distributing, and supporting biomedical equipment, devices, and software globally for large- and mid-cap healthcare companies and venture-backed start-ups. His passion is creating and leading high-performing teams, especially in fast-growth environments facing significant challenges alongside technical, operational, and commercial professionals.
From Sunrise to Suntra: A Broader Vision
Sunrise Labs, known for its technical and engineering expertise, has evolved into Suntra MedTech Solutions, offering a more holistic approach to product development. Gilpin noted that the company now helps clients not only solve engineering problems but also connect strategy, innovation, and execution, ensuring faster and safer market entry for medical devices. The name change was driven by the realization that the original name no longer reflected the company’s expanded capabilities and vision. “Suntra” blends the spirit of “Sunrise” with “transformation,” which is at the heart of every medical breakthrough.
The name change comes as the medtech industry demands speed, safety, and certainty. Suntra aims to meet these needs by providing integrated product development, a method that brings together diverse teams from the outset to streamline the process and reduce risks. This shift shows the company’s commitment to being a future-ready partner for innovators, while maintaining the trust and promise that defined Sunrise Labs for over 30 years.
Integrated Development: The Future of MedTech
Gilpin emphasized the importance of breaking down silos in product development. By having engineering, clinical, regulatory, marketing, and manufacturing teams collaborate from the start, Suntra aims to enhance decision-making and accelerate the delivery of impactful medical products. This approach contrasts with traditional siloed methods, which often lead to delays and increased risks. Integrated development ensures that all aspects of a product’s lifecycle are considered simultaneously, supporting better collaboration and sharper decision-making.
